Drug-induced rise in serum creatinine: cystatin C to the rescue? Evidence, pitfalls and knowledge gaps.

Serum creatinine (SCr) concentration is a cheap biomarker of kidney function measured globally millions of times every day. It is part of the KDIGO definitions of both chronic kidney disease and acute kidney injury (AKI). However, SCr can be elevated following the introduction of a new medication, unrelated to reduced glomerular filtration rate (GFR) and may lead to medical misjudgment, with clinically significant consequences. Indeed, several antibacterial, antiviral, antifungal or antiparasitic agents, fibrates or corticosteroids have been linked to increases in SCr unrelated to kidney injury (pseudo-AKI). More recently, multiple classes of targeted anti-cancer treatments like tyrosine kinase inhibitors, PARP inhibitors or CDK 4/6 inhibitors have also been associated with pseudo-AKI. The mechanisms responsible are multiple and diverse, ranging from interference with the method of creatinine measurement to inhibition of renal tubular secretion of creatinine via various transporters. Cystatin C measurement can help discern between true and pseudo-AKI but some interactions also exist and data is lacking. In cases where a precise assessment of kidney function is needed, GFR can also be measured through plasma and urinary clearance of an exogenous marker, therefore removing the inaccuracies of the various eGFR equations. Here, we propose a narrative review, exploring for the first time in depth drugs associated with pseudo-AKI. Creatinine and cystatin C metabolism, methods of measurement and derived equations are discussed as well. We also propose a decision-making algorithm to help the clinician in daily practice.

• Publication year

  2025

• Venue

  European journal of internal medicine

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejim.2025.106592PMID 41224604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Association of Fibrate Use with Kidney Outcomes and Mortality

  2025cited by this paper
• Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C

  2024cited by this paper
• Bempedoic Acid, the First-in-Class Oral ATP Citrate Lyase Inhibitor with Hypocholesterolemic Activity: Clinical Pharmacology and Drug–Drug Interactions

  2024cited by this paper
• Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.

  2024cited by this paper
• Iohexol Plasma Clearance Measurement Protocol Standardization for Adults - a Consensus Paper of the European Kidney Function Consortium.

  2024cited by this paper
• Which is the best glomerular filtration marker: Creatinine, cystatin C or both?

  2024cited by this paper
• KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

  2024cited by this paper
• The Effects of Pantoprazole on Kidney Outcomes

  2024cited by this paper
• Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

  2023cited by this paper
• Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker

  2023cited by this paper
• Diagnostic standard: assessing glomerular filtration rate.

  2023cited by this paper
• Impact of thrice-weekly cotrimoxazole prophylaxis on creatinine and potassium plasma levels in kidney transplant recipients

  2023cited by this paper
• Discordances Between Creatinine and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.

  2023cited by this paper
• Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex.

  2023cited by this paper
• A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil.

  2023cited by this paper
• Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study

  2023cited by this paper
• Anaplastic lymphoma kinase inhibitors and their effect on the kidney

  2022cited by this paper
• Cystatin C in addition to creatinine for better assessment of glomerular renal function decline in people with HIV receiving antiretroviral therapy

  2022cited by this paper
• Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.

  2022cited by this paper
• Effect of Pemafibrate on Serum Creatinine in Patients with Chronic Kidney Disease

  2022cited by this paper
• Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study

  2022cited by this paper
• Targeted Cancer Therapies Causing Elevations in Serum Creatinine Through Tubular Secretion Inhibition: A Case Report and Review of the Literature

  2022cited by this paper
• Comparison of Renal Function Biomarkers of Serum Creatinine and Cystatin C in HIV-Infected People on Dolutegravir-Containing Therapy

  2022cited by this paper
• Ribociclib-Induced Pseudo-Acute Kidney Injury

  2022cited by this paper
• Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality

  2022cited by this paper
• The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies

  2022cited by this paper
• A Prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors.

  2022cited by this paper
• Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case Report.

  2021cited by this paper
• Assessment of kidney function: clinical indications for measured GFR

  2021cited by this paper
• Is trimethoprim/sulfamethoxazole-associated increase in serum creatinine a pseudo-elevation or true nephrotoxicity?

  2021cited by this paper
• Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors

  2021cited by this paper
• In Vitro and In Vivo Inhibition of MATE1 by Tyrosine Kinase Inhibitors

  2021cited by this paper
• Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy

  2021cited by this paper
• Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis

  2021cited by this paper
• The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.

  2021cited by this paper
• New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

  2021cited by this paper
• Cefoxitin-Serum Creatinine Interference in a Patient With Nontuberculous Mycobacteria Ventriculomeningitis

  2020cited by this paper
• KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.

  2020cited by this paper
• Rifampicin and isoniazid behave as non-creatinine chromogens and interfere with Jaffe's reaction: A phenomenon with the potential to give a false-positive result in creatinine estimation.

  2020cited by this paper
• Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine

  2020cited by this paper
• The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).

  2020cited by this paper
• Impact of Very Low-Dose Trimethoprim-Sulfamethoxazole on Serum Creatinine after Renal Transplantation: A Retrospective Study.

  2020cited by this paper
• Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies

  2020cited by this paper
• Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration

  2020cited by this paper
• A real or apparent decrease in glomerular filtration rate in patients using olaparib?

  2020cited by this paper
• Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate

  2020cited by this paper
• Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder

  2020cited by this paper
• Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects

  2020cited by this paper
• PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance

  2020cited by this paper
• ANNALS EXPRESS: The influence of a cooked-fish meal on estimated glomerular filtration rate.

  2019cited by this paper
• Biomarkers of Acute and Chronic Kidney Disease.

  2019cited by this paper
• Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors

  2019cited by this paper
• CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions

  2019cited by this paper
• GFR-estimation by serum creatinine during glucocorticosteroid therapy

  2018cited by this paper
• Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents

  2018cited by this paper
• Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART

  2018cited by this paper
• Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1

  2018cited by this paper
• Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials

  2018cited by this paper
• Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat.

  2018cited by this paper
• Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate

  2018cited by this paper
• Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model.

  2017cited by this paper
• Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2.

  2017cited by this paper
• Clinical benefits of using inulin clearance and cystatin C for determining glomerular filtration rate in HIV-1-infected individuals treated with dolutegravir.

  2017cited by this paper
• In vitro assessment of the roles of drug transporters in the disposition and drug–drug interaction potential of olaparib

  2017cited by this paper
• Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid Leukemia.

  2016cited by this paper
• Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review

  2016cited by this paper
• Corticosteroids Significantly Increase Serum Cystatin C Concentration without Affecting Renal Function in Symptomatic Heart Failure.

  2016cited by this paper
• Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management.

  2014cited by this paper
• Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

  2014cited by this paper
• A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.

  2013cited by this paper
• In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor

  2013cited by this paper
• Stable Cystatin C Serum Levels Confirm Normal Renal Function in Patients With Dronedarone-Associated Increase in Serum Creatinine

  2013cited by this paper
• Estimating glomerular filtration rate from serum creatinine and cystatin C.

  2012cited by this paper
• Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C

  2012cited by this paper
• Spuriously raised serum creatinine associated with an excipient present in an intravenous dexamethasone formulation

  2012cited by this paper
• Effects of fibrates in kidney disease: a systematic review and meta-analysis.

  2012cited by this paper
• Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function

  2012cited by this paper
• Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins

  2011cited by this paper
• Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

  2011cited by this paper
• Prediction of Fluoroquinolone‐Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion

  2011cited by this paper
• Trimethoprim, Creatinine and Creatinine-Based Equations

  2011cited by this paper
• Potent and Specific Inhibition of mMate1-Mediated Efflux of Type I Organic Cations in the Liver and Kidney by Pyrimethamine

  2010cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells

  2009cited by this paper
• The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine

  2009cited by this paper
• Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people.

  2008cited by this paper
• The influence of a cooked-meat meal on estimated glomerular filtration rate

  2007cited by this paper
• Lack of Effect of DX-619, a Novel Des-Fluoro(6)-Quinolone, on Glomerular Filtration Rate Measured by Serum Clearance of Cold Iohexol

  2007cited by this paper
• Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2.

  2006cited by this paper
• The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

  2006cited by this paper
• Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.

  2006cited by this paper
• Effect of dronedarone on renal function in healthy subjects

  2005cited by this paper
• Glucocorticoids and the kidney

  2003cited by this paper
• Effect of Ciprofibrate on Lipoproteins, Fibrinogen, Renal Function, and Hepatic Enzymes

  2002cited by this paper
• Fenofibrate Increases Creatininemia by Increasing Metabolic Production of Creatinine

  2002cited by this paper
• Fibrate treatment can increase serum creatinine levels.

  2001cited by this paper
• Fibrate treatment can increase serum creatinine levels

  2001cited by this paper
• Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

  2000cited by this paper
• Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper

• No citing papers are available for this paper.